维普中文期刊产品整合服务
50篇 您的检索式:作者名="Ciferri"
    题名 作者 年代 出处 被引量
1螺旋藻——食用微生物(续二)显示文摘生物化学人们已通过钝顶螺旋藻和巨大螺旋藻的凝胶电泳分析出藻兰蛋白[29]——一种与光合作用有关的胆蛋白,并从前者中分离出这种化合物。C—藻兰蛋白和异藻兰蛋白两者显然都是在变性条件下可被电泳法分离的,至少由两种不同亚基所组成的少基数(Oligomeri)复合物。C—藻兰蛋白的α—亚基和β—亚基显示出与各自20500和23—500的分子量相当的易变性,从而形成一个具有最低分子量约44000的少基,异藻兰蛋白是由分子量约为18000和20000的亚基构成的,从而可形成一个最低分子量约为38000的少基。Orio Ciferri 林励 李万瑶 1989海南大学学报(自然科学版)1989,7,4:2
2螺旋藻——食用微生物显示文摘绪言 1944年法国藻类学家丹觉亚德(Dangeard)在波尔德奥克斯(Bordeaux)林奈学会的一份通讯中描述了一种样品,该样品系由驻扎在拉密城堡的法国殖民军药剂师柯力亚克(Creach)先生提供的。那时拉密城堡属于法兰西属的赤道非洲部分,现在属于乍得共和国。这种样品是从位于乍得湖东边约50km的小村庄——马塞可里(Massakory)市场中买到的。Orio Ciferri 林励 李万瑶 1989海南大学学报(自然科学版)1989,7,2:2
3Mesophase formation and chain rigidity in cellulose and derivatives, 4:cellulose in N, N-Dimethylacetamide-Lithium chloride显示文摘Bianchi E Ciferri A Conio G 1985Macromolecules1985,18,:1
4Production of a mino acids by analog-resistant mutants of the cyanobacteriun Spirulina platensis显示文摘Riccard G Sora S Ciferri O 1981J Bacteriol1981,147,3:1
5Spirulina, the edible micro- organism 显示文摘CIFERRI O 1983Microbiological Reviews1983,47,:1
6Platelets are essential for leukocyte recruitment in allergic inflammation显示文摘Simon C. Pitchford Hiroshi Yano Rebecca Lever Yanira Riffo-Vasquez Silvia Ciferri Mark J. Rose Silvia Giannini Stefania Momi Domenico Spina Brian O'Connor Paolo Gresele Clive P. Page 2003The Journal of Allergy and Clinical Immunology2003,,1:1
7Supramolecular polymerizations显示文摘Ciferri A 2002Macromolecular Rapid Communications2002,23,9:1
8Architecture and flex- ibility of the yeast Ndc80 kinetochore complex 显示文摘Wang HW Long S Ciferri C 2008J Mol Biol2008,383,4:1
9Implications for kinetochore - mierotubule attachment from the structure of an engineered Ndc80 complex 显示文摘Ciferri C Pasqualato S Screpanti E 2008Cell2008,133,3:1
10Mechanism of aurora B activation by INCENP and inhibition by hesperadin 显示文摘Sessa F Mapelli M Ciferri C 2005Mol Cell2005,18,3:1
11Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study显示文摘AIM To report adalimumab(Ada) efficacy on articulargastrointestinal disease and health-related quality of life(HRQo L) in patients with enteropathic spondyloarthritis(ES).METHODS A cohort of 52 patients with ES was evaluated in the departments of gastroenterology and internal medicine. At baseline, all patients underwent assessment by an integrated gastro-rheumatologic evaluation of articular and gastrointestinal activity, as well patient reported outcomes(PROs) of the HRQo L questionnaires. After this integrated evaluation and following a specific working flowchart, the Ada anti-tumor necrosis factor(TNF)-inhibitor was assigned to a cohort of 30 patients and its clinical efficacy was evaluated at baseline and after 6-mo and 12-mo treatment by the following tests:(1) Ankylosing Spondylitis Disease Activity ScoreC-Reactive Protein(ASDAS-CRP); Bath Ankylosing Spondylitis Disease Activity Index(BASDAI), Bath Ankylosing Spondylitis Functional Index(BASFI) and Bath Ankylosing Spondylitis Metrology Index(BASMI) for articular activity;(2) Inflammatory Bowel Disease Questionnaire(IBDQ), Crohn's Disease Activity Index(CDAI) and partial Mayo(p Mayo) score for gastrointestinal symptoms and activity; and(3) Health Assessment Questionnaire(HAQ), Patient Global Assessment(PGA) and Short Form-36 health survey(SF-36) questionnaires for PROs of the HRQo L.RESULTS Integrated evaluation and management of the patients affected by ES, carried out simultaneously by a gastroenterologist and a rheumatologist, allowed clinicians to choose the optimal therapeutic strategy. In a cohort of 30 ES patients affected by active articular and gastrointestinal disease, or axial active articular inflammation, Ada led to fast and sustained improvement of both articular and gastrointestinal disease activities. In fact, all the clinimetric evaluation tests exploring articular or gastrointestinal activity, as well as all the HRQo L scores, showed a significant improvement having been achieved at the earliest(6-mo) assessment. This important clinical improvement was maintained at the 12-mo follow-up. Importantly, global and gastrointestinal quality of life significantly correlated with articular disease activity, providing evidence to support that the integrated evaluation is the best option to manage patients with ES.CONCLUSION Ada treatment, upon multidisciplinary(gastrorheumatologic) evaluation, significantly improves both articular and gastrointestinal inflammation, thereby improving the HRQo L in patients affected by ES.Michele Maria Luchetti Devis Benfaremo Francesco Ciccia Laura Bolognini Monia Ciferri Alessia Farinelli Matteo Rossini Piergiorgio Mosca Giovanni Triolo Armando Gabrielli 2017World Journal of Gastroenterology2017,23,39:1
12Spirulina:the edible microorganism显示文摘Orio Ciferri 1983Microbiological Reviews1983,47,4:1
13The NdcS0 complex: hub of kinetochore activity显示文摘Ciferri C Musacchio A Petrovic A 2007FEBS Lett2007,581,15:1
14Empowering integration processes with data provenance 显示文摘Tomazela B Hara C S Ciferri R R 2013Data & Knowledge Engineering2013,86,5:1
15Microbial degradation of paintings显示文摘Ciferri O 1999Applied and Environmental Microbiology1999,65,3:1
16Kinetochore mi- crotubule dynamics and attachment stability are regulated by Hecl显示文摘DeLuca JG Gall WE Ciferri C 2006Cell2006,127,5:1
17Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes显示文摘Ciferri C Chandramouli S Donnarumma D Nikitin P A Cianfrocco M A Gerrein R Feire A L Barnett S W Lilja A E Rappuoli R 2015Proc Natl Acad Sci2015,,20:1
18Platelcts release their lysosomal Content in vivo in humans upon activation显示文摘 Emiliani C Guglielmini G 2000Thromb Haemost2000,83,1:1
19The microbial degradation of silk:a laboratory investigation显示文摘Annamaria Seves Maria Romano Orio Ciferri 1998International Biodeterioration & Biodegradation1998,42,:1
20Abacterial extracellular proteinase degrading silk fibroin显示文摘Giuseppe Forlani Anna Maria Seves Orio Ciferri 2000International Biodeterioration & Biodegradation2000,46,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费